Stock listing
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
Selected listing: 2591 · HKEX · HKD · HK
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (HKEX:2591), Health Technology. Latest release Sep 28, 2026: Interim Report 2026.
- Ticker
- HKEX:2591
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
About Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
Interim Report 2026
September 28, 2026
Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa
August 4, 2026
Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
May 29, 2026
All Guangzhou Innogen Pharmaceutical Group Co Ltd Class H news →
Research Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H company profile
View the public company page for Guangzhou Innogen Pharmaceutical Group Co Ltd Class H on 6ix.
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H news
Read company news and market updates connected to Guangzhou Innogen Pharmaceutical Group Co Ltd Class H.
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H investor events
Find investor webinars, events, and replay context for Guangzhou Innogen Pharmaceutical Group Co Ltd Class H.